Clinical trials
Brain Ischemia trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ludwig-Maximilians - University of Munich | 2 |
| University Hospital Schleswig-Holstein | 2 |
| Charite University, Berlin, Germany | 1 |
| D-Pharm Ltd. | 1 |
| European Society of Anaesthesiology | 1 |
| Klinikum St. Georg gGmbH | 1 |
| Neuravi Inc. | 1 |
| Neuravi Limited | 1 |
| University of Erlangen-Nürnberg Medical School | 1 |
| Wuerzburg University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Ischemia | 13 |
| Stroke | 9 |
| Cerebrovascular Disorders | 6 |
| Ischemic Stroke | 6 |
| Brain Diseases | 5 |
| Brain Infarction | 4 |
| Vascular Diseases | 4 |
| Central Nervous System Diseases | 3 |
| Ischemia | 3 |
| Nervous System Diseases | 3 |
Trials
Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.